tigecycline
3074A1-3331
Phase 3 small_molecule completed
Quick answer
tigecycline for Community-Acquired Infections is a Phase 3 program (small_molecule) at Wyeth is now a wholly owned subsidiary of Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Wyeth is now a wholly owned subsidiary of Pfizer
- Indication
- Community-Acquired Infections
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed